ADVFN Logo ADVFN

No pudimos encontrar ningún resultado para:
Asegúrate de que la ortografía sea correcta o intenta ampliar tu búsqueda.

Tendencias Ahora

Listas Principales

Parece que no has iniciado sesión.
Haz clic en el botón de abajo para iniciar sesión y ver tu historial reciente.

Hot Features

Registration Strip Icon for monitor Monitoree múltiples cotizaciones en tiempo real de los principales intercambios, como la Bolsa de Valores de Londres, NASDAQ, NYSE, AMEX, Bovespa y más.

ADTX Aditxt Inc

1.92
-0.03 (-1.54%)
31 May 2024 - Cerrado
Retrasado por 15 minutos
Nombre de la Acción Símbolo de la Acción Bolsa de Valores Tipo de Valor
Aditxt Inc ADTX NASDAQ Acción Común
  Variación del Día (ptos.) Variación del Día (%) Último Precio Hora
-0.03 -1.54% 1.92 19:00:00
Precio de Apertura Precio Mínimo Precio Máximo Precio de cierre Precio Anterior
1.95 1.92 2.00 1.92 1.95
más cotizaciones de acciones »

Noticias Recientes

Fecha Hora Fuente Noticia
29/5/202415:33EDGAR2Form PRE 14A - Other preliminary proxy statements
28/5/202405:08EDGAR2Form 8-K - Current report
22/5/202415:24EDGAR2Form 8-K - Current report
20/5/202415:15EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
15/5/202405:50PRNUSEvofem Biosciences Announces Financial Results for the First..
13/5/202415:15EDGAR2Form 8-K - Current report
08/5/202415:15EDGAR2Form 8-K - Current report
07/5/202415:15EDGAR2Form 8-K - Current report
03/5/202413:14BWCORRECTING and REPLACING Aditxt Announces Pricing of $4.2..
03/5/202408:00BWAditxt Announces Pricing of $4.2 Million Private Placement..
02/4/202407:30BWAditxt Signs a Definitive Agreement to Acquire Appili..
27/3/202407:36PRNUSEvofem Reports $18.2 million of Phexxi Net Product Sales in..
11/3/202415:51EDGAR2Form 8-K - Current report
07/3/202406:54PRNUSFor Women Using GLP-1 Receptor Agonists who take Oral Birth..
04/3/202416:27EDGAR2Form 425 - Prospectuses and communications, business..
04/3/202416:24EDGAR2Form 8-K - Current report
01/3/202415:01EDGAR2Form 8-K - Current report
29/2/202415:01EDGAR2Form 8-K - Current report
22/2/202416:21EDGAR2Form 8-K/A - Current report: [Amend]
21/2/202415:30EDGAR2Form 8-K - Current report
16/2/202415:30EDGAR2Form 8-K - Current report
15/2/202415:30EDGAR2Form 8-K - Current report
14/2/202408:26EDGAR2Form S-1/A - General form for registration of securities..
09/2/202415:31EDGAR2Form 8-K - Current report
06/2/202415:30EDGAR2Form 8-K - Current report
02/2/202415:28EDGAR2Form 425 - Prospectuses and communications, business..
02/2/202415:26EDGAR2Form 8-K - Current report
01/2/202407:00PRNUSEvofem Biosciences Announces Strong Preliminary Results,..
30/1/202416:28EDGAR2Form 8-K - Current report
30/1/202415:30EDGAR2Form 8-K - Current report
30/1/202407:30BWAditxt, Inc. Acquires Proprietary Electroencephalography..
23/1/202415:18EDGAR2Form D - Notice of Exempt Offering of Securities
19/1/202415:15EDGAR2Form 8-K - Current report
18/1/202415:30EDGAR2Form S-1 - General form for registration of securities under..
09/1/202416:19EDGAR2Form 425 - Prospectuses and communications, business..
09/1/202416:16EDGAR2Form 8-K - Current report
08/1/202407:30BWAditxt, Inc.’s Subsidiary Pearsanta, Inc. Acquires MDNA Life..
05/1/202415:30EDGAR2Form 8-K - Current report
05/1/202407:45EDGAR2Form 8-K - Current report
05/1/202407:30BWAditxt Announces Closing of $6.0 Million Private Placement..
02/1/202407:45EDGAR2Form 8-K - Current report
02/1/202407:30BWAditxt, Inc. Regains Compliance with Nasdaq Stockholders’..
29/12/202316:07BWAditxt Announces $6 Million Private Placement Priced..
26/12/202316:26EDGAR2Form 8-K - Current report
22/12/202316:00EDGAR2Form 8-K - Current report
22/12/202315:30EDGAR2Form 8-K - Current report
21/12/202315:30EDGAR2Form 8-K - Current report
12/12/202316:09EDGAR2Form 425 - Prospectuses and communications, business..
12/12/202316:04EDGAR2Form 8-K - Current report
12/12/202307:30BWAditxt, Inc. Enters into Definitive Agreement to Acquire..